Recipharm to acquire Corvette Pharmaceutical Services Group for SEK 1.1 billion
|
|
- Miranda Quinn
- 7 years ago
- Views:
Transcription
1 Jordbro, 19 th August 2014 Press release Recipharm to acquire Corvette Pharmaceutical Services Group for SEK 1.1 billion The contract development and manufacturing organisation, Recipharm AB has signed an agreement to acquire Milan based Corvette Pharmaceutical Services Group (Corvette) from Italian private equity Group LBO Italia Investimenti s.r.l. Highlights Corvette had 2013 revenue and EBITDA of EUR 57.7 million (SEK 499 million) and EUR 15 million (SEK 130 million) respectively. The combined entity will enhance Recipharm s scale and profitability. Based on 2013 proforma financials, the combined entity s revenue and EBITDA would have been SEK 2.6 billion and SEK 408 million respectively. The transaction values Corvette at an enterprise value EUR 120 million (SEK 1.1 billion) with estimated net debt of EUR 20 million (SEK 183 million). The estimated equity consideration of EUR 100 million will be paid for by 50% cash and 50% in the form of a convertible bond. No additional financing is required. The deal provides access to highly interesting geographical areas including Italy and a number of emerging markets, many of which are new to Recipharm. Recipharm will have an asset base in each of the five largest European pharmaceutical markets. Corvette has a stable and reputable customer base with little overlap with Recipharm thus presenting significant cross-selling opportunities. Increases manufacturing capacity and strengthened capability in the highly sought after technology of lyophilisation. Corvette will contribute to Recipharm s Intellectual Property (IP) backed manufacturing business as Corvette s IP portfolio supports circa 40% of their sales. Accretive to profitability and EPS with both set to increase already in Closing expected on 1 st October 2014 following Recipharm s Extraordinary General Meeting ( EGM ) to authorise the Board of Directors to issue the convertible bond.
2 Thomas Eldered, CEO: The acquisition of Corvette is very much in line with our strategic plan and we are very excited to have secured such a high quality company. We will be gaining access to a first class and largely new customer base as well as new capabilities and capacities that will add to our technology base. Italy is an extremely interesting market made up of many small and mid-size companies where Recipharm currently has little presence. This combined with the significant sales in emerging markets represents an exciting opportunity. We are therefore looking forward to combining the assets of both organisations and working together with the management of Corvette to deliver benefit to all of our stakeholders. About Corvette Pharmaceutical Services Group Corvette Pharmaceutical Services Group (consisting of Corvette Group SpA and LIO Immobiliare s.r.l.) has three manufacturing facilities located in the Milan region of Northern Italy. Each facility specialises in a different technology and business area: Masate - Sterile injectable manufacturing facility with capabilities for both lyophilisation and liquid filling of vials and ampoules including hormones supplied to numerous territories including Japan. Paderno Dugnano - API and finished dose form development and manufacturing facility with a number of owned product rights including Erdosteine, an important mucolytic product. The facility supplies the global market including the US and Japan. Lainate - Bulk lyophilisation of sterile beta lactam antibiotics supplied to numerous markets including Japan. Around 265 people are employed across the three facilities and over 100 customers are served including big pharma, mid-size speciality pharma as well as global generic companies. Reported net sales in 2013 amounted to EUR 57.7 million with an EBITDA of EUR 15.0 million giving an EBITDA margin of 26% and operating profit (EBIT) of EUR 11.4 million. The net asset position at 31 st December 2013 was EUR 25.2 million. The first six months of trading in 2014 is performing well with an improvement in both net sales and EBITDA compared to the same period last year. All reported numbers are according to Italian GAAP. Transaction rationale Enhanced Reach, Scale and Profitability. Access to new and highly interesting geographies including Italy and emerging markets. 45% of Corvette s sales are in Italy. 20% of sales are to Emerging Markets. Recipharm will now have manufacturing assets in the five largest European pharmaceutical markets. Access to a new customer base presenting significant opportunities for cross selling. Approximately 80% of Corvette sales are to customers new to Recipharm. Increased lyophilisation capacity and capabilities. Strengthens Recipharm s leadership in lyophilisation. Addresses current and short term capacity shortage whilst new capacity comes on stream in Recipharm s existing facility. Ability to handle hormones in both vials and ampoules. Significant Intellectual Property. Some 40% of Corvette s sales are backed by own IP (including marketing authorisations, product rights and patents) with a promising pipeline of new products. Supports Recipharm s ambition to include more IP in its offering.
3 Future potential royalties from the possible approval of Erdosteine as an orphan drug in the US for the treatment of bronchiectasis. Vertically integrated development. Development and small scale manufacturing of niche active pharmaceutical ingredients integrated with finished dose form development Provides access to new manufacturing contracts derived from development pipeline. Attractive financial impact. Corvette s profitable business having 26% EBITDA margin will increase average combined margin. Corvette has many years of strong development in both sales and EBITDA and will contribute to combined organic growth. The acquisition is expected to be accretive to EPS Additional, non-quantified benefits from commercial synergies, cross-selling to customers and operational optimisation. Transaction terms Consideration and financing. The equity consideration, estimated to EUR 100 million, is to be paid 50% in cash and 50% in the form of a senior unsecured convertible bond issued to the sellers. Corvette will have approximately EUR 21 million in interest bearing debt which will be repaid after closing. The cash for the transaction is already available and no additional external financing is required. The sellers will be entitled to 15% of any potential Erdosteine net royalties yielded from its US orphan drug indication for a period of ten years from closing. Senior unsecured convertible bond terms. Issued to seller, LBO Italia Investimenti s.r.l. Issue size: Preliminary EUR 50 million. Issue price: 100% of par. Coupon: None. Security: Unsecured. Maturity date: 30 th September Lock-up on shares: Until 31 st March 2015 Conversion period: From closing until 9 th September Conversion terms: Partial or full conversion into new Recipharm Class B shares. Conversion price is SEK 91.10, calculated based on a volume weighted average of the ten trading days before Aug 19. At full conversion, with a fixed exchange rate of SEK/EUR, this would represent approximately 5 million new shares, close to 12% of share capital and 3.2% of the voting rights. Redemption price: 90% of par, equal to EUR 45 million. Listing: None. Other terms and conditions as customary to convertible bonds. Values are preliminary and will be finally determined at closing. Proforma Financial Summary 2013 PF (msek) Recipharm Corvette 1 Total Change (%) Net sales EBITDA EBITDA margin(%) Based on 2013 average exchange rate SEK/EUR of 8.65
4 Timetable The closing of the transaction is expected to be 1 st October There are no material conditions to closing. To obtain authorisation for the Board of Directors to issue the convertible bond, Recipharm will convene an Extraordinary General Meeting, scheduled for 11 th September B&E Participation AB, owned by Thomas Eldered and Recipharm Chairman Lars Backsell, that controls 44.6 % of the Recipharm total share capital and 86.4 % of the voting rights, will vote in favour of the convertible bond issue. The joint lead managers in Recipharm s IPO, Carnegie and SEB, have, for this transaction, given their written consent to release Recipharm from the lock-up on carrying out new share issues. The lock-up was undertaken in the placing agreement in the IPO. For the avoidance of doubt, the lockup agreement undertaken by B&E Participation AB in connection with the IPO will remain. Conference call Q&A A conference call with a web presentation will be held today at 0900hrs CET. To participate in the conference, please dial: From Sweden, tel: From Denmark, tel: From Finland, tel: From Norway, tel: From the UK, tel: From Germany, tel: From France, tel: From Spain, tel: From Switzerland, tel: From the US, tel: From Italy, tel: Pin code for participants: # To access the presentation use the following link: For further information please visit or contact: Thomas Eldered, CEO, thomas.eldered@recipharm.com, telephone: Björn Westberg, CFO, bjorn.westberg@recipharm.com, telephone: This information is published in accordance with the Swedish Securities Market Act, the Swedish Financial Instruments Trading Act and/or the regulations of NASDAQ OMX Stockholm. This information was submitted for publication on 19 th August, 2014, at 7:45 am CET. About Recipharm Recipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry based in Sweden employing some 1,500 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and pharmaceutical product development. Recipharm currently manufactures more than 200 different products to both Big Pharma and smaller research- and development companies. Recipharm s turnover is approximately SEK 2.1 billion and the Company operates development and manufacturing facilities in Sweden, France, the UK, Germany and Spain and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq OMX Stockholm. For more information on Recipharm and our services, please visit Recipharm has retained White & Case and Setterwalls as legal advisors for the transaction.
5 About the LBO Italia Investimenti Srl The sellers of Corvette Group are LBO Italia Investimenti Srl ( LBO Italia ), as controlling shareholder, and some private investors, holding minority interests. LBO Italia is a holding company controlled by Europe Capital Partners V S.C.A., SICAR ( ECP V ) a private equity fund raised with institutional as well as private investors. LBO Italia targets investments in Italian midsized companies. Its experience runs from finance to industry and management. Europe Capital Partners began working in private equity in the 80s and pioneered the field in continental Europe. ECP V follows four other funds which collectively completed over sixty private equity investments throughout Europe. ECP V's general partner and the LBO Italia management team are significant co-investors in the firm's acquisitions. For further information visit For further information on Corvette visit In the sale of Corvette Pharmaceutical Services Group, LBO Italia has retained Rothschild as financial advisor and d Urso, Gatti e Bianchi and Gernandt & Danielsson as legal advisors.
Recipharm creates a global CDMO leader through SEK 1.7 billion strategic acquisitions in the US, Sweden and India
Press release 18 th April 2016 Recipharm creates a global CDMO leader through SEK 1.7 billion strategic acquisitions in the US, Sweden and India Recipharm AB (publ) ( Recipharm or the Company ) announces
More informationTELE2 OFFERS SEK 75 PER SHARE FOR SONG NETWORKS
FOR IMMEDIATE RELEASE September 22, 2004 TELE2 OFFERS SEK 75 PER SHARE FOR SONG NETWORKS Tele2 AB ( Tele2 ), the leading alternative pan-european telecommunications company, today announced a cash offer
More informationNordic Waterproofing announces its initial public offering on Nasdaq Stockholm and prospectus in connection therewith
PRESS RELASE Helsingborg, Sweden, 30 May 2016 Nordic Waterproofing announces its initial public offering on Nasdaq Stockholm and prospectus in connection therewith IN WHICH THE DISTRIBUTION OR RELEASE
More informationHoist Finance announces its intention to launch an initial public offering and listing on Nasdaq Stockholm
Press release Stockholm 26 February 2015 Hoist Finance announces its intention to launch an initial public offering and listing on Nasdaq Stockholm Hoist Finance AB (publ) ( Hoist Finance or the Company
More informationSweco acquires Grontmij. Creating the leading European engineering consultancy
Sweco acquires Grontmij Creating the leading European engineering consultancy 1 Sweco will make a recommended public offer to buy all shares in Grontmij. In other words: Sweco and Grontmij will combine
More informationPress Release from Securitas AB. Securitas to list three new specialized security companies on the Stockholm Stock Exchange
Press Release from Securitas AB The Board of Securitas AB proposes: February 9, 2006 Securitas to list three new specialized security companies on the Stockholm Stock Exchange Securitas AB, a world leader
More informationCapio intends to be listed on the Nasdaq Stockholm Stock Exchange
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR PUBLICATION IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SINGAPORE
More informationREVENUES UP 29% TO 137.2 MILLION & NET INCOME UP 33% TO 7.6 MILLION
FOR IMMEDIATE RELEASE 25 April 2006 REVENUES UP 29% TO 137.2 MILLION & NET INCOME UP 33% TO 7.6 MILLION Luxembourg, 25 April 2006 Transcom WorldWide S.A. ( Transcom ) (Stockholmsbörsen: TWWA, TWWB), the
More informationInvestor Growth Capital Stephen Campe
Investor Growth Capital Stephen Campe Head of Investor Growth Capital Agenda 1. Rationale for Investor Growth Capital and strategy 2. Business overview and setup 3. Our value creation model 4. The portfolio
More informationDOCDATA N.V. and Ingram Micro reach agreement on the sale of the e-commerce service company Docdata to Ingram Micro
To be distributed on Tuesday 13 October 2015 Continental Time 23.30h. U.K. 22.30h. / U.S. Eastern Standard Time 17.30h. DOCDATA N.V. and Ingram Micro reach agreement on the sale of the e-commerce service
More informationPascal Quiry July 2010
Please send any questions on this case study to the author via the mail box on the web site www.vernimmen.net Pascal Quiry July 2010 This document may not be used, reproduced or sold without the authorisation
More informationRusForest Strengthens Equity by SEK 450 million and Secures Russian Strategic Investor
PRESS RELEASE RusForest Strengthens Equity by SEK 450 million and Secures Russian Strategic Investor Intended offer to bondholders of debt restructuring, whereby the bond s nominal amount and accrued interest
More informationInterim report January - March 2015
Interim report January - March 2015 April 22 th 2015 Lars Wollung, CEO Erik Forsberg, CFO Q1 Key highlights Strong financial performance EBIT excluding revaluations and fx-impact +12% Investment grade
More informationCapital Stage AG, Conference Call, Monday, 11/17/14 Strategic Partnership with Gothaer Insurance Group
Capital Stage AG, Conference Call, Monday, 11/17/14 Strategic Partnership with Gothaer Insurance Group Who we are We are an independent operator of PV and wind parks in Germany, Italy and France. Over
More informationThe Tender Offer does not correspond to tender offers as stipulated in Article 27, Section 2-1 of Japan s Financial Instruments and Exchange Law.
February10, 2015 Canon Inc. Chairman & CEO: Fujio Mitarai Securities code: 7751 [Tokyo (First section) and other Stock Exchanges] Inquiries: Shinichi Aoyama General Manager Consolidated Accounting Division
More informationTOMAS CARLSSON, PRESIDENT AND CEO JONAS DAHLBERG, CFO Q2 2015 17 JULY
TOMAS CARLSSON, PRESIDENT AND CEO JONAS DAHLBERG, CFO Q2 2015 17 JULY 1 Q2 highlights Strong profitability and organic growth +15% EBITA adj for calender and E/O 10% organic growth in 3 of 4 BAs Actions
More informationInterim report April-June 2003
Interim report April-June 2003 Pre-tax profit for the second quarter amounted to SEK -34m, which is a SEK 30m improvement compared to last year (SEK -64m). Software revenue grew by 5% during the second
More informationLuxonen S.A. In Voluntary Liquidation
Luxonen S.A. In Voluntary Liquidation April 2013 LUXONEN S.A. Mailing address: P.O Box 871, L-2018, Luxembourg Phone: +352 22 95 15 Contents Page 1. Summary 2. 2. Terms and instructions 3. 3. Liquidator
More informationQ2 report 2015 Press- and analyst presentation
Q2 report 2015 Press- and analyst presentation 19 August 2015 Per Strömberg, CEO Sven Lindskog, CFO Q2 Highlights: Solid second quarter 2015 Stable financial development Improved net sales +15% +4.3% excl
More informationH1 2015 Audio webcast RESULTS PRESENTATION. July 30, 2015
H1 2015 Audio webcast RESULTS PRESENTATION July 30, 2015 DISCLOSURE This presentation contains no confidential material and may include publicly available market information which has not been independently
More informationVattenfall three-month Interim Report 2002 January - March
1 Vattenfall three-month Interim Report 2002 January - March Presentations by Lars G Josefsson, CEO and Matts Ekman, CFO May 15, 2002 2 Highlights Net sales more than doubled to SEK 28.4 billion Return
More informationTHE NT EUROPE (EX-UK) EQUITY INDEX FUND SUPPLEMENT TO THE PROSPECTUS DATED 17 NOVEMBER 2014 FOR NORTHERN TRUST INVESTMENT FUNDS PLC
THE NT EUROPE (EX-UK) EQUITY INDEX FUND SUPPLEMENT TO THE PROSPECTUS DATED 17 NOVEMBER 2014 FOR NORTHERN TRUST INVESTMENT FUNDS PLC 1 2 Supplement dated 17 November 2014 to the Prospectus dated 17 November
More informationQUALITY THROUGH SPECIALISATION Presentation Q1 29 April 2009
QUALITY THROUGH SPECIALISATION Presentation Q1 29 April 2009 Background information An international health care company Specialised clinics within specific areas; spine, dental, orthopaedics, bariatrics,
More informationTHE NT EUROPE (ex-uk) EQUITY INDEX FUND
THE NT EUROPE (ex-uk) EQUITY INDEX FUND 1 2 02 Supplement to the Prospectus Northern Trust Investment Funds plc THE NT EUROPE (ex-uk) EQUITY INDEX FUND 3 This Supplement contains specific information in
More informationActive Biotech Group Interim Report 1 January 30 September 1999
Active Biotech Group Interim Report 1 January 30 September 1999 The new annual forecast shows a considerably better result. Sale of the property in Solna expected to be completed before the end of the
More informationSOPRA-STERIA GROUP. Merger project Creation of a European leader in digital transformation
SOPRA-STERIA GROUP Merger project Creation of a European leader in digital transformation DISCLAIMER This presentation may contain forward-looking statements concerning Groupe Stéria and Sopra Group. Such
More informationAnnouncement of prospectus and offer to the shareholders of CSE
Press Release, December 16, 2004 Announcement of prospectus and offer to the shareholders of CSE On November 15, 2004, OMX AB (publ) ( OMX ) and Copenhagen Stock Exchange A/S ( CSE ) announced plans to
More informationABB Annual Report 2006 Financial summary. Power and productivity for a better world
ABB Annual Report 2006 Financial summary Power and productivity for a better world This is ABB Rising demand for energy and its impact on the environment are the defining challenges of this century. ABB
More informationInterim Management Report. for the Bolzoni Group
Interim Management Report for the Bolzoni Group at 31 March 2011 1 INDEX Corporate offices pg. 3 Group activity pg. 5 Group structure pg. 6 Comments of the Directors on the Company s performance pg. 7
More informationNunaMinerals: Notice of extraordinary general meeting
NunaMinerals: Notice of extraordinary general meeting Nuuk, 20 January 2015 Announcement no. 03/2015 Page 1 of 15 The meeting will be held on Thursday, 29 January 2015 at Hotel Hans Egede, Nuuk at 4.00
More informationAtos to enhance its global leadership in digital services
Atos to enhance its global leadership in digital services Atos to acquire Xerox IT outsourcing operations Atos and Xerox to enter in a worldwide strategic collaboration Atos would acquire Xerox s IT Outsourcing
More informationFull year report January December 2015
Full year report January December 215 Telephone conference February 12, 216 Thomas Berglund, CEO Olof Bengtsson, CFO Continued improvements in Capio Nordic and Germany France almost compensated for the
More informationOur people make the difference
Transcom WorldWide S.A. Our people make the difference Investor Presentation Q1 2006 1 Company Overview Transcom is Europe s largest CRM operator by geographic footprint Fast growing Customer Relationship
More informationCOMPANY PRESENTATION OF THE TERMS FOR TRANSATLANTIC S DEBT CERTIFICATES 2013
COMPANY PRESENTATION OF THE TERMS FOR TRANSATLANTIC S DEBT CERTIFICATES 2013 This summary of the terms and conditions for Rederi AB Transatlantic s (publ) (the Issuer ) maximum SEK 140,000,000 senior unsecured
More informationDPP - DSM in motion: driving focused growth DSM and JLL create leading pharma services company in US$ 2.6bn transaction 19 November 2013.
DPP - DSM in motion: driving focused growth DSM and JLL create leading pharma services company in US$ 2.6bn transaction 19 November 2013 Page Safe harbor statement This presentation may contain forward-looking
More informationOrc Software AB Interim report January 1 March 31, 2005
Orc Software AB Interim report January 1 March 31, 2005 Revenue for January-March 2005 increased by 2 percent compared to the equivalent period in the previous year and amounted to SEK 66 (65) million.
More informationLong-term asset manager and active owner of Nordic listed companies
Long-term asset manager and active owner of Nordic listed companies Full Year 2015 February 5, 2016 Year-End presentation 12M 2015 1 Summary 12 months, 2015 The total return for the year was 15% for the
More informationQuarterly Report 1/2004
Quarterly Report 1/2004 Operating revenues increased in 1 th quarter to NOK 1407.0 mill. Operating profit decreased to NOK 5.4 mill. The operations of the Moelven Timber Group have been affected by the
More informationNASDAQ OMX MAXIMUM ACCESS AND VISIBILITY TOWARDS GLOBAL AND LOCAL INVESTORS
MAXIMUM ACCESS AND VISIBILITY TOWARDS GLOBAL AND LOCAL INVESTORS JOIN THE WORLD S MOST RECOGNIZED BRANDS Listed Companies 2 OUR GLOBAL LISTINGS BUSINESS 8 LISTING OPPORTUNITIES U.S. NORDICS BALTICS LISTINGS
More informationBiotie Therapies Oyj Biotie Therapies Corp. Varsinainen yhtiökokous 26.5.2015 Annual General Meeting 26 May 2015
Biotie Therapies Oyj Biotie Therapies Corp. Varsinainen yhtiökokous 26.5.2015 Annual General Meeting 26 May 2015 1 Timo Veromaa President & CEO 2 Company Highlights 2014 through Q1 2015 Continued advances
More informationInterim Report January 1 st March 31 st, 2003
Interim Report January 1 st March 31 st, 2003 First Quarter 2003 Earnings before taxes increased by 23 per cent to 70 MSEK. Earnings after taxes increased by 36 per cent to 45 MSEK. Earnings per share
More informationNOBINA AB INVESTOR PRESENTATION, Q3, SEPTEMBER NOVEMBER 2015
NOBINA AB INVESTOR PRESENTATION,, SEPTEMBER NOVEMBER 2015 LARGEST PUBLIC TRANSPORT COMPANY IN THE NORDIC REGION Nobina s economies of scale, market expertrise and outstanding bus fleet, combined with long-term
More information30 January 1998 FOR IMMEDIATE RELEASE
Proposed acquisition of LGT Asset Management Division and Preliminary Results for the year ended ember 1997 30 January 1998 FOR IMMEDIATE RELEASE The Board of AMVESCAP PLC has entered into an agreement
More informationInterim Report First Quarter 2011 Stockholm April 20, 2011
Interim Report First Quarter 2011 Stockholm April 20, 2011 Summary of Q1 2011 Good volume growth, revenues up 10% and 17% adjusted for currency Negative impact from FX and full effect of price cuts in
More informationINVESTOR CALL RESULTS OF THE FISCAL YEAR 2014/15
INVESTOR CALL RESULTS OF THE FISCAL AR 2014/15 Mannheim, 13 May 2015 Oliver Windholz CEO Helmut Fischer CFO Disclaimer 2015 PHOENIX Pharmahandel GmbH & Co KG This document has been prepared by PHOENIX
More informationWeak 2003 positive outlook for 2004
Teleca AB (publ) Year-end Report, January - December, 2003 Weak 2003 positive outlook for 2004 Sales increased 17% to SEK 2,456 M (2,090). International sales corresponded to 48% of total sales Earnings
More informationPRESS RELEASE. Pierrel S.p.A.
PRESS RELEASE Pierrel S.p.A. The Board of Directors approved: - the draft Financial Statement of Pierrel S.p.A. and the Consolidated Financial Statement of the Group as at 31 December 2009 Consolidated
More informationTrustBuddy AB (publ.)
Interim report first quarter 2015 The Board of TrustBuddy AB (publ.), listed on NASDAQ First North, leaving the following quarterly report for January March 2015 TrustBuddy AB (publ.) First quarter in
More informationShare redemption 2016
Share redemption 2016 Information for shareholders in HiQ International AB (publ) regarding the Board s proposal for a share split and mandatory redemption procedure Background BACKGROUND HiQ International
More informationRandstad announces a recommended cash offer to the shareholders of Proffice
Randstad Holding nv P.O. Box 12600 NL-1100 AP Amsterdam z.o. T +31 (0)20 569 59 11 This press release may not be published or distributed, directly or indirectly, in or into Australia, Canada, Hong Kong,
More informationCorporate Governance and Shareholder Activism
Corporate Governance and Shareholder Activism Julian Franks London Business School and ECGI July 9 /3 Forces that make for effective corporate governance A board that makes decisions that are in the interests
More informationNet profit/loss for the period, KSEK 38 228 19 283 5 455 9 774. Private equity fund investments, KSEK 461 248 359 840
Page 1 of 16 NAXS Nordic Access Buyout Fund AB (publ) Interim report January September 2012 Nine months 2012 Net profit/loss for the period amounted to KSEK 38,2 (19,3). Earnings per share amounted to
More informationMunksjö Oyj A global leader in specialty paper
Munksjö Oyj A global leader in specialty paper SEB Enskilda Nordic Seminar, Copenhagen, 8 January 2014 Jan Åström, President and CEO Important notice This document may not be distributed in or into Australia,
More informationA taste for action Tele2 in pole position
1Quarterly Report January March 23 A taste for action Tele2 in pole position Tele2 reports record cash flow of SEK 1.4bn before investments, with EBT increasing to MSEK 491, while adding 91, customers
More informationInterim Report for the period 1 January 31 March 2015
Interim Report for the period 1 January 31 March 2015 ALL FIGURES IN THIS REPORT ARE EXPRESSED IN SEK, UNLESS STATED OTHERWISE. FIGURES IN PARENTHESES REFER TO THE CORRESPONDING FIGURES FOR THE PREVIOUS
More informationInvestor & Analyst Presentation Acquisition of Centor US Holding Inc. Uwe Röhrhoff, CEO Rainer Beaujean, CFO Duesseldorf, July 28, 2015
Investor & Analyst Presentation Acquisition of Centor US Holding Inc. Uwe Röhrhoff, CEO Rainer Beaujean, CFO Duesseldorf, July 28, 2015 Disclaimer 1. This presentation may contain certain forward-looking
More informationInterim report January June 2015
Interim report January June Second quarter Gross cash collections SEK 834m EBIT margin 30% Acquisition of loan portfolios SEK 665m CET1 ratio 12.58% April June, year-on-year Gross cash collections increased
More informationA strong third quarter
A strong third quarter Interim presentation for the third quarter 2015 Stockholm, 5 November 2015 Anders Nissen, CEO Liia Nõu, CFO Today s agenda Introduction Financial review Business model and value
More informationIN THE FIRST QUARTER 2004 TELE2 INCREASED ITS REVENUES BY 20% WHILE OPERATING CASH FLOW INCREASED TO SEK 1.6 BILLION
FOR IMMEDIATE RELEASE Wednesday, April 21, 2004 IN THE FIRST QUARTER 2004 TELE2 INCREASED ITS REVENUES BY 20% WHILE OPERATING CASH FLOW INCREASED TO SEK 1.6 BILLION New York and Stockholm Wednesday, April
More informationINTERIM REPORT JANUARY 1 JUNE 30, 2010
INTERIM REPORT JANUARY 1 JUNE 3, 21 April to June quarter totalled 334.6 (324.2) The operating profit/loss was.7 (4.9) The profit/loss before tax was.6 (5.6) The profit/loss after tax was.2 (3.9), corresponding
More informationAdecco returns to growth in October
Adecco returns to growth in October Improving revenue trends and strong profitability in Q3 2013 Q3 2013 HIGHLIGHTS Revenues flat in constant currency Gross margin of 18.7%, up 80 bps SG&A down 2% in constant
More informationQuarter 1 2009 presentation. 13 May 2009 Lars Nilsen, CEO and Arnt Eriksen, CFO
Quarter 1 2009 presentation 13 May 2009 Lars Nilsen, CEO and Arnt Eriksen, CFO Q1 2009 Highlights Group Operating revenues; NOK 677 million, Down 21.2% y/y Acceptable EBITDA margin; 10.6% EBITDA NOK 72
More informationVattenfall Q2 2013 results
Vattenfall Q2 2013 results Øystein Løseth, CEO and Ingrid Bonde, CFO Conference call for analysts and investors, 23 July 2013 Q2 Highlights Impairment charges on thermal assets and goodwill amounting to
More informationNASDAQ LadderRite USD Corporate Bond Indexes
NASDAQ LadderRite USD Corporate Bond Indexes OVERVIEW NASDAQ LadderRite USD Corporate Bond Indexes are diversified, laddered bond portfolios. Each NASDAQ LadderRite USD Corporate Bond Index tracks a diversified
More informationShare redemption programme
Share redemption programme 2014 Information for shareholders in Sectra AB (publ) ahead of the Annual General Meeting on 8 September 2014 regarding the Board s proposal for a share split and mandatory redemption
More informationSweco and Grontmij to create Europe s leading engineering consultancy
This is a joint press release by Grontmij N.V. and Sweco AB pursuant to the provisions of Section 5, paragraph 1 and Section 7, paragraph 4 of the Decree on Public Takeover Bids (Besluit Openbare Biedingen
More information*See note 4 to our Summary Financial Information table below concerning our current operational and reporting structure
INTERIM REPORT 1(39) Nokia Corporation Interim Report for Q1 2014 FINANCIAL AND OPERATING HIGHLIGHTS First quarter 2014 highlights for continuing operations*: Nokia s non-ifrs diluted EPS in Q1 2014 of
More informationFull Year Results 2014
Full Year Results 2014 18 March 2015 Conference call on FY Results 2014 Corporate Finance & Investor Relations AGENDA FY 2014 results presentation Highlights 2014 Financials 2014 Outlook 2015 Appendix
More informationPRESS RELEASE 2015-12-15
PRESS RELEASE 2015-12-15 Balder acquires an additional 22.9 per cent of SATO mandates Carnegie and SEB to evaluate the possibility to implement a directed issue in order to partially finance the acquisition
More informationASX Announcement Takeover bid for Vision Eye Institute
6 July 2015 ASX Announcement Takeover bid for Vision Eye Institute Pulse Health Limited ( Pulse ; ASX: PHG) is pleased to announce a takeover bid for Vision Eye Institute Limited ( Vision ; ASX: VEI) comprising
More informationInformation regarding share split and redemption of shares in AB Volvo 2007
Information regarding share split and redemption of shares in AB Volvo 2007 The share split and redemption procedure in summary Table of contents 2 The share split and redemption procedure in summary 3
More informationCarnegie Investment Bank AB (publ) Year-end report
Carnegie Investment Bank AB (publ) (Corp. reg. no. 516406-0138) Year-end report 1 January 31 December 2009 Carnegie Investment Bank AB (publ) is a leading independent investment bank with Nordic focus.
More informationNOTICE OF EXTRAORDINARY GENERAL MEETING IN BONG AB (publ)
This is a non-official translation of the Swedish original wording. In case of differences between the English translation and the Swedish original, the Swedish text shall prevail. NOTICE OF EXTRAORDINARY
More informationInterim Report January June 2001
556025-5001 31 July 2001 Interim Report January June 2001 Quarter January-June MSEK 2001 II 2001 I 2000 II 2001 2000 Net turnover, MSEK 1,742 1,840 1,612 3,582 3,200 Operating profit, MSEK 319 469 290
More informationOrder bookings 48,719 55,565-12 12,835 14,845 Sales 48,331 56,492-14 13,166 17,076
28 January, 2002 SCANIA YEAR-END REPORT JANUARY - DECEMBER 2001 After the unsatisfactory 2001, our measures to adjust production to lower global demand, structural changes related to cab production and
More informationTHE BOARD OF DIRECTORS APPROVES THE HALF-YEARLY REPORT AT 3O JUNE 2007: CONSOLIDATED NET INCOME: 9.1 MILLION ( 16.1 MILLION IN FIRST HALF 2006)
CAMFIN s.p.a. PRESS RELEASE THE BOARD OF DIRECTORS APPROVES THE HALF-YEARLY REPORT AT 3O JUNE 2007: CONSOLIDATED NET INCOME: 9.1 MILLION ( 16.1 MILLION IN FIRST HALF 2006) NET INCOME FROM INVESTMENTS:
More informationGTECH Acquisition of IGT
GTECH Acquisition of IGT Creating the World s Leading End-to-End Gaming Company July 16, 2014 Forward-looking Statements This presentation contains forward-looking statements (including within the meaning
More informationTELE2 AB ANNOUNCES SIGNIFICANT CUSTOMER INTAKE DRIVING STRONG OPERATING RESULTS FOR THE 12 MONTHS ENDED DECEMBER 31, 2000
FOR IMMEDIATE RELEASE Tuesday, February 20, 2001 TELE2 AB ANNOUNCES SIGNIFICANT CUSTOMER INTAKE DRIVING STRONG OPERATING RESULTS FOR THE 12 MONTHS ENDED DECEMBER 31, 2000 53% Annualized increase in Group
More informationSTRATEGY UPDATE 2 MARCH 2016
STRATEGY UPDATE 2 MARCH 2016 Portfolio Focus on Attractive Growth and Margin Opportunities André Lacroix, CEO Intertek Group plc, is today announcing a strategic update outlining the Group s plan to deliver
More informationX5 RETAIL GROUP TO ACQUIRE KOPEYKA DISCOUNTER CHAIN:
X5 RETAIL GROUP TO ACQUIRE KOPEYKA DISCOUNTER CHAIN: BUILDS ON SOFT DISCOUNTERS SUCCESS AND ADDS TO X5 S OPPORTUNITIES FOR LEADERSHIP, GROWTH AND VALUE CREATION LONG-TERM RUBLE FINANCING FOR TRANSACTION
More informationQ1 Trading Update, FY 2011
ARYZTA AG Q1 Trading Update, FY 2011 29 November 2010 Forward Looking Statement This document contains forward looking statements which reflect management s current views and estimates. The forward looking
More informationEnvestnet to Acquire Yodlee
For Immediate Release Envestnet to Acquire Yodlee Combination accelerates the transformation of financial technology by delivering better relationships and greater lifetime value by connecting financial
More informationVattenfall Full Year 2013 results
Vattenfall Full Year 2013 results Øystein Løseth, CEO and Ingrid Bonde, CFO Press conference, 4 February 2014 2013 Highlights Net sales increased 2.6% to SEK 172bn (167) Underlying EBIT increased 1.3%
More informationthe Nordic Region Page 1
Leading Mail and Logistics Operator in the Nordic Region Page 1 Created by the Biggest Merger of its kind in Europe PostNord AB was created through the merger of Posten AB and Post Danmark A/S in 2009
More informationFIRST QUARTER 2005. Highlights from first quarter 2005 include: Operating profit 10 MNOK (42 MNOK last year)
FIRST QUARTER 2005 Highlights from first quarter 2005 include: Revenues 599 MNOK (+1 percent relative to first quarter 2004) Operating profit 10 MNOK (42 MNOK last year) Acquisition of Orwak Group completed
More informationINFORMATION REGARDING PROPOSED REDEMPTION OF SHARES IN BETSSON AB
2015 INFORMATION REGARDING PROPOSED REDEMPTION OF SHARES IN BETSSON AB Betsson AB s core business consists of investing and administering shareholding in companies, which through partners or by themselves,
More informationConsolidated revenue for the period is 21 822 (18 694) KSEK, up 17% compared to the same period last year.
Financial and operational highlights April June 2013 Consolidated revenue for the period is 21 822 (18 694) KSEK, up 17% compared to the same period last year. Operating result for the period is 4 524
More informationDeutsche Global Infrastructure Fund (TOLLX)
Global Infrastructure Fund (TOLLX) A step beyond MLPs Important risk information Any fund that concentrates in a particular segment of the market will generally be more volatile than a fund that invests
More informationSALES GROWTH AND INCREASED OPERATING MARGIN
SALES GROWTH AND INCREASED OPERATING MARGIN SUMMARY FOR JANUARY-SEPTEMBER 2015 Net sales SEK 448,3 M (350,4) Profit before tax SEK 67,8 M (42,4) Operating margin 16 % (13) Earnings per share before dilution
More informationYear-end report for the period 1 January 31 December 2015. Revenue in the fourth quarter increased by 28 per cent
Year-end report for the period 1 January 31 December 2015 ALL FIGURES IN THIS REPORT ARE EXPRESSED IN SEK, UNLESS STATED OTHERWISE. FIGURES IN PARENTHESES REFER TO THE CORRESPONDING PERIOD FOR THE PREVIOUS
More informationInterim Report for the period 1 January 30 September 2015. Revenue in the third quarter increased by 24 per cent
Interim Report for the period 1 January 30 September 2015 ALL FIGURES IN THIS REPORT ARE EXPRESSED IN SEK, UNLESS STATED OTHERWISE. FIGURES IN PARENTHESES REFER TO THE CORRESPONDING PERIOD FOR THE PREVIOUS
More informationConference Call Annual Results 2013/14
AT&S first choice for advanced applications Conference Call Annual Results 2013/14 Andreas Gerstenmayer (CEO) Karl Asamer (CFO) Martin Theyer (IR/PR) 8th May 2014 8:30am CET AT & S Austria Technologie
More informationPrivate banking in Italy: Holistic advisory for family-run business in an increasingly globalised environment
Private banking in Italy: Holistic advisory for family-run business in an increasingly globalised environment by Andrea Cingoli, Banca Esperia SpA The Italian private banking sector is developing a new
More informationJoining forces with. Hamburg, 5 October 2015
Joining forces with Hamburg, 5 October 2015 AGENDA Key facts of the acquisition Acciona S.A. / Acciona Windpower at a glance Key elements of the acquisition Strategic rationale Main areas of value creation
More informationH & M Hennes & Mauritz AB
Nine-month report (1 Dec - 31 August ) H & M Hennes & Mauritz AB Nine-month report Nine-months (1 December 31 August ) The H&M Group s sales including VAT increased in local currencies by 15 percent during
More informationOld Mutual Acquisition of United Asset Management. 19 June 2000
Old Mutual Acquisition of United Asset Management 19 June 2000 0 Speakers Johannesburg Mike Levett Old Mutual - Chairman and C.E.O. London Eric Anstee Old Mutual - Group Finance Director Boston James F.
More informationFull Year Report 2005. 26 January 2006
Full Year Report 2005 26 January 2006 Important Notice This Presentation has been produced by TradeDoubler AB (the Company ) and is furnished to you solely for your information. This document contains
More informationBrown Advisory WMC Strategic European Equity Fund Class/Ticker: Institutional Shares / BAFHX Investor Shares / BIAHX Advisor Shares / BAHAX
Summary Prospectus October 30, 2015 Brown Advisory WMC Strategic European Equity Fund Class/Ticker: Institutional Shares / BAFHX Investor Shares / BIAHX Advisor Shares / BAHAX Before you invest, you may
More informationOur strategy in todays challenging market. Oslo 15 January 2015
Our strategy in todays challenging market Oslo 15 January 2015 The company Arise is one of the largest independent wind power operators in Sweden with the business model to: Sell electricity produced by
More informationHow does a venture capitalist appraise investment opportunities?
1 How does a venture capitalist appraise investment opportunities? Michael Queen - Finance Director, 3i Group plc A presentation to: 23 Pensions Convention 2 June 23 A How presentation does a venture to:
More information